Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-030233
Filing Date
2022-11-02
Accepted
2022-11-02 17:15:17
Documents
44
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 672041
2 ex31.htm EX-31 20022
3 ex32.htm EX-32 6711
  Complete submission text file 0001493152-22-030233.txt   3507427

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clcs-20220331.xsd EX-101.SCH 28172
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clcs-20220331_cal.xml EX-101.CAL 38974
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clcs-20220331_def.xml EX-101.DEF 142691
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clcs-20220331_lab.xml EX-101.LAB 252783
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clcs-20220331_pre.xml EX-101.PRE 198318
38 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 476591
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 221355213
SIC: 2834 Pharmaceutical Preparations